Jm. Blondeau et al., Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin, INT J ANT A, 10(4), 1998, pp. 297-302
We tested 1503 clinical isolates of Pseudomonas aeruginosa, from 48 Canadia
n medical centers, against ciprofloxacin and 11 other antimicrobial agents
to determine in vitro activity. The frequency of susceptibility was highest
for carbenicillin and ticarcillin (91% each) followed by imipenem and ceft
azadime (90% each). Overall susceptibility(< 1.0 mg/l) to ciprofloxacin was
84% while resistance (greater than or equal to 4.0 mg/l) was 12%. Ciproflo
xacin resistant isolates were more common from urinary tract specimens than
from specimens collected from the respiratory and/or skin and soft tissue.
Isolates from cystic fibrosis patients were more resistant to all agents t
ested than isolates from non-cystic fibrosis patients. (C) 1998 Published b
y Elsevier Science B.V. and International Society of Chemotherapy. All righ
ts reserved.